Category Archives: Cancer

Breastcancer doesn’t discriminate. Neither should medicine prices

Picture Courtesy: TAC Twitter

Posted in Campaign for Affordable Trastuzumab, Cancer, Drug prices, Uncategorized | Tagged | Leave a comment

Demonstrations held at Roche & pharma associations in South Africa, Malaysia, UK, France, Zambia, Brazil, US

Source: TAC Tuesday, 7th February 2017 –* Swiss multinational company Roche faced global condemnation today from women living with cancer, families of people with cancer, activists, scientists, researchers and health professionals from across the world. They highlighted the immoral and unconscionable tactics employed by … Continue reading

Posted in Cancer, Evergreening, Patent, Uncategorized | Leave a comment

Treatment activists at International AIDS Conference, Durban stand in solidarity with breast cancer survivors who need the lifesaving drug ‘trastuzumab’

Roche has a worldwide monopoly on the breast cancer drug ‘trastuzumab’ (marketed under the brand name Herceptin). In South Africa women with HER2 breast cancer can’t afford the drug as it costs ½ a million Rand (approximately USD 34,000 or … Continue reading

Posted in Cancer, Protest&Campaigns, Uncategorized | Leave a comment

Colombia Asked To Declare Excessive Price For Cancer Drug Contrary To Public Interest, Grounds For Compulsory License

IP Watch, December 3, 2015. By James Love and Andrew S. Goldman. Colombia has a decision to make. A full year has passed from the November 24, 2014 request by iFarma, Misión Salud and CIMUN for a declaration of the public interest … Continue reading

Posted in Cancer, Compulsory Licensing | Leave a comment

Delhi HC upholds Roche’s patent claims on Tarceva against Cipla

Economic Times, November 28, 2015. Mumbai – A division bench of the Delhi High Court sided with Roche against Indian firm Cipla, upholding the Swiss drug maker’s patent claims on key lung cancer drug erlotinib hydrochloride, branded Tarceva. The ruling is … Continue reading

Posted in Cancer, Patent infringement, Sec 3 (d) | Leave a comment

Swiss drugmaker Roche launches costliest cancer drugs in India

Economic Times, November 26, 2015. Mumbai: As insurers, patients and governments across the world debate over the rising cost of healthcare, Swiss pharmaceutical major Roche has boldly launched two new drugs for late-stage breast cancer, pricing them higher than any other … Continue reading

Posted in Biologics/Biosimilars, Cancer, Pricing | Leave a comment

Delhi HC blocks Reliance from launching copy of Roche’s breast cancer drug

ET Healthworld; November 6, 2015. NEW DELHI: The Delhi High Court has blocked Reliance Life Sciences from launching a copy of Swiss pharma company Roche’s breast cancer drug trastuzumab.

Posted in Cancer, Patent Injunction | Leave a comment